GALACTOSE
Substance profile for UNII X2RN3Q8DNE, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#
- UNII
- X2RN3Q8DNE
- Preferred term
- GALACTOSE
- Registry number
- 59-23-4
- EC number
- 200-416-4
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C6H12O6

Chemical And Database Identifiers#
- InChIKey
- GZCGUPFRVQAUEE-KCDKBNATSA-N
- SMILES
- OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O
- RxCUI
- 4626
- PubChem
- 3037556
- NCIt
- C68482
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 3037556 | |
| PubChem InChIKey Search | GZCGUPFRVQAUEE-KCDKBNATSA-N | |
| RxNorm | 4626 | |
| NCI Thesaurus | C68482 | |
| FDA Substance Registration System | X2RN3Q8DNE | |
| European Community number | 200-416-4 |
DailyMed Socrata Ingredients#
| DailyMed label | SPL version |
|---|---|
| LACTULOSE SOLUTION, USP | 1 |
| LACTULOSE SOLUTION [HI-TECH PHARMACAL CO., INC.] | 3 |
| LACTULOSE SOLUTION [UNIT DOSE SERVICES] | 3 |
| LACTULOSE SOLUTION [HI-TECH PHARMACAL CO., INC.] | 2 |
Inactive Ingredient Database#
| Ingredient | UNII | CAS | Dosage form | Route | Potency | Maximum daily exposure |
|---|---|---|---|---|---|---|
| GALACTOSE | X2RN3Q8DNE | 19217073 | POWDER, FOR SOLUTION | ORAL | NA | |
| GALACTOSE | X2RN3Q8DNE | 19217073 | SOLUTION | ORAL | 2200 mg/15ml | |
| GALACTOSE | X2RN3Q8DNE | 19217073 | TABLET | ORAL | 0.67 mg | |
| GALACTOSE | X2RN3Q8DNE | 19217073 | SOLUTION | RECTAL | 14.67 %w/v |